Literature DB >> 16295542

DHF in infants, late infants and older children: a comparative study.

Prasonk Witayathawornwong1.   

Abstract

A comparative study of dengue hemorrhagic fever in infants and children was conducted at the Department of Pediatrics, Phetchabun Hospital between May,1999 and December, 2002. There were 1,924 DHF patients (aged 0-14 years). There were 40 (2.1%) infants (age 0-l years) and 27 (1.4%) young children (age 1-2 years). Sixty-seven cases (3.5%) of the older children (> 2-14 years) were selected to be compared. The clinical and epidemiological data for each of the three groups were not statistically different from each other, except for age, splenomegaly, shock state and mode of dengue infection. Older children were more likely to have a second dengue infection and a shock state than younger patients. Laboratory investigation results and fluid management for each of the three groups were not significantly different from each other except for the total WBC (min), neutrophils (max), lymphocytes (max) and platelets (min). The platelets (min) in the infants were significantly lower than in the younger children and the older children. Associated symptoms, diseases, complications, and hematologic manifestations in each of the three groups were not significantly different from each other except for the presence of coryza, seizures, nausea/vomiting, rash, and petichiae. Coryza, seizures, nausea/vomiting, rash, and petichiae in the infants and younger children were significantly different from the older children.

Entities:  

Mesh:

Year:  2005        PMID: 16295542

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  7 in total

Review 1.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

2.  Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.

Authors:  Anna P Durbin; Sandra V Mayer; Shannan L Rossi; Irma Y Amaya-Larios; Jose Ramos-Castaneda; Eng Eong Ooi; M Jane Cardosa; Jorge L Munoz-Jordan; Robert B Tesh; William B Messer; Scott C Weaver; Nikos Vasilakis
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

Review 3.  Dengue--quo tu et quo vadis?

Authors:  Rubing Chen; Nikos Vasilakis
Journal:  Viruses       Date:  2011-09-01       Impact factor: 5.048

4.  Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study.

Authors:  Tauqeer Hussain Mallhi; Amer Hayat Khan; Azreen Syazril Adnan; Azmi Sarriff; Yusra Habib Khan; Fauziah Jummaat
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

Review 5.  Mosquito-transmitted viruses - the great Brazilian challenge.

Authors:  Mânlio Tasso de Oliveira Mota; Ana Carolina Terzian; Maria Luana Cristiny Rodrigues Silva; Cássia Estofolete; Maurício Lacerda Nogueira
Journal:  Braz J Microbiol       Date:  2016-10-27       Impact factor: 2.476

Review 6.  Dengue in infants: an overview.

Authors:  Amita Jain; Umesh C Chaturvedi
Journal:  FEMS Immunol Med Microbiol       Date:  2010-03-17

7.  Socio-demographic inequalities in the clinical characteristics of dengue haemorrhagic fever in the city of Rio de Janeiro, Brazil, 2007-2008.

Authors:  Sheila Moura Pone; Yara Hahr Marques Hökerberg; Patricia Brasil; Cecília Carmen de Araújo Nicolai; Rogério Ferrari; Raquel de Vasconcellos Carvalhaes de Oliveira
Journal:  Epidemiol Infect       Date:  2018-01-17       Impact factor: 4.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.